News
In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.
REFILE-POC test for chlamydia, gonorrhea as good as lab-based assays
(Fixes typo in para 3 of May 19 story.) By Anne Harding NEW YORK (Reuters Health) - A new 30-minute point-of-care (POC) test using self-collected vaginal swabs works as well as lab-based molecular
REFILE-Elevated fecal calprotectin points to intestinal inflammation in COVID-19 patients
(Fixes typo in para 10 of story posted May 19) By Scott Baltic NEW YORK (Reuters Health) - New data showing elevated fecal calprotectin (FC) levels in COVID-19 patients add to mounting evidence that
Visual and auditory training improve different aspects of schizophrenia
By Marilynn Larkin NEW YORK (Reuters Health) - Visual training and auditory training were "differentially efficient" at improving cognitive deficits and symptoms in a randomized trial of schizophrenia
New genetic tool could one day diagnose rheumatic disease faster than a clinician
By Marilynn Larkin NEW YORK (Reuters Health) - A novel diagnostic tool that combines a patient's own genetic data with genetic risk scores zeroed in on the most probable diagnosis among five different
UPDATE 1-Does drug touted by Trump work on COVID-19? After data debacle, we still don't know
(Adds retraction of Lancet article, repeats story to additional clients) By Kate Kelland and Alistair Smout LONDON (Reuters) - Scientists are resuming COVID-19 trials of the now world-famous drug
Protesters should 'highly consider' coronavirus tests, U.S. health official says
By Michael Erman NEW YORK (Reuters) - A top U.S. health official cautioned on Thursday that protests sweeping across the country could increase the spread of the novel coronavirus, particularly in
Advanced melanoma more prevalent among unmarried patients
By Lisa Rapaport (Reuters Health) - Single adults are more likely to be diagnosed with advanced melanoma and have shorter overall survival than their married counterparts, a recent study suggests.
Extensive financial ties between industry and U.S. medical society leaders
By Lisa Rappaport (Reuters Health) - Almost three quarters of leaders of U.S. professional medical associations have financial ties to industry, a new study suggests. Researchers examined 2017-2019
U.S. doctors group sues FDA for limiting access to drug touted by Trump for COVID-19
By Allison Martell and Michael Erman (Reuters) - A group of conservative U.S. doctors has sued the Food and Drug Administration for limiting use of the malaria drug hydroxychloroquine for COVID-19,
Study authors retract influential Lancet hydroxychloroquine article
By Reuters Staff NEW YORK (Reuters) - Three of the authors of an influential article that found hydroxychloroquine increased the risk of death in COVID-19 patients retracted the study on Thursday,
AstraZeneca targets 2 bln doses, poor countries with COVID vaccine deals
By Reuters Staff (Reuters) - British drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to 2 billion doses in two deals involving Microsoft billionaire Bill
Vaccines group raises $8.8 bln for immunisation plans for poor countries
By Kate Kelland LONDON (Reuters) - The GAVI vaccines alliance said on Thursday it had raised $8.8 billion from international donor governments, companies and philanthropic foundations to fund its
African countries secure 90 million coronavirus test kits for next six months
By Giulia Paravicini ADDIS ABABA (Reuters) - African countries have secured 90 million test kits for the novel coronavirus for the next six months, a regional disease control body said on Thursday,
Europe pins hopes on smarter coronavirus contact tracing apps
By Douglas Busvine MUEHLBACH AM MANHARTSBERG, Austria (Reuters) - European countries cautiously emerging from the onslaught of the coronavirus pandemic are looking to a second generation of contact
FEATURE-For Venezuelans, a key obstacle for handwashing during pandemic - no running water
By Vivian Sequera and Johnny Carvajal CARACAS (Reuters) - After going two months without running water at her home on the outskirts of Venezuela's capital Caracas, Mara Loyo stores it whenever it
'This is not New York': Mexico president defends coronavirus response
By Reuters Staff MEXICO CITY (Reuters) - Mexican President Andres Manuel Lopez Obrador defended his government's handling of the coronavirus on Thursday after official data showed new deaths for a 24-
U.S. working with manufacturers to boost flu vaccine availability, top official says
By Michael Erman NEW YORK4 (Reuters) - The U.S. government is working with drugmakers to maximize availability of influenza vaccines, worried that a substantial flu season on top of another wave of
Egypt to prosecute doctor, father over genital cutting of three girls
By Menna A. Farouk CAIRO (Thomson Reuters Foundation) - Egyptian authorities have said they will prosecute the father of three girls who they say were tricked into undergoing female genital mutilation
Savolitinib might improve outcomes in some patients with papillary renal-cell carcinoma
By Will BOggs MD NEW YORK (Reuters Health) - Savolitinib appears to improve outcomes in patients with MET-driven papillary renal-cell carcinoma (PRCC) compared with sunitinib, the standard of care,
First-line pembrolizumab boosts progression-free survival in advanced colorectal cancer with specific mutations
By Megan Brooks NEW YORK (Reuters Health) - Upfront therapy with the immune-checkpoint inhibitor pembrolizumab doubled progression-free survival compared with chemotherapy in patients with
REFILE-Benzodiazepine use could raise fracture risk in kids
(Fixes formatting issue affecting some clients; no change to text) By Megan Brooks NEW YORK (Reuters Health) - Starting a benzodiazepine in a child with an anxiety disorder could raise the risk for
Tyson the alpaca takes heavyweight role in search for coronavirus vaccine
By Reuters Staff STOCKHOLM (Reuters) - Scientists in Sweden are hoping an alpaca named Tyson can help deliver a knockout blow in the fight to develop a treatment or vaccine against the novel
REFILE-COVID-19 exacts high toll in patients with diabetes
(Refiling Jun 3 story to fix formatting problem affecting some clients, with no change to text.) By Megan Brooks NEW YORK (Reuters Health) - About one in 10 patients with diabetes dies within seven
Benzodiazepine use could raise fracture risk in kids
By Megan Brooks NEW YORK (Reuters Health) - Starting a benzodiazepine in a child with an anxiety disorder could raise the risk for upper- and lower-limb fractures, but the association was only
Nurses developed eye cysts while treating COVID-19 patients
By Carolyn Crist NEW YORK (Reuters Health) - Nurses in Paris developed eye problems while using eye protection to care for critically ill patients in COVID-19 intensive-care wards, according to a new
Lumpectomy for multiple ipsilateral breast tumors yields satisfying cosmetic results: survey
By Megan Brooks NEW YORK (Reuters Health) - Most women with multiple tumors in a single breast are pleased with the cosmetic results of lumpectomy, despite loss of significant breast volume and often
Acute stroke care delayed during COVID-19 pandemic
By Will Boggs MD NEW YORK (Reuters Health) - The time between stroke onset and hospital arrival has increased by about one hour since the beginning of the COVID-19 outbreak, researchers in Hong Kong
Florida offers drive-through Botox to quarantined residents
By Zachary Fagenson MIAMI (Reuters) - Quarantined Florida residents worried about their laughter lines and crows' feet need frown no longer - Botox is back, and it's being offered at a drive-through.
Amazon is sued over warehouses after New York worker brings coronavirus home, cousin dies
By Jonathan Stempel NEW YORK (Reuters) - Amazon.com Inc has been sued for allegedly fostering the spread of the coronavirus by mandating unsafe working conditions, causing at least one employee to
Thailand's 1 million health volunteers hailed as coronavirus heroes
By Jiraporn Kuhakan and Panu Wongcha-um SALADANG, Thailand (Reuters) - Nearly every day, 77-year-old Surin Makradee goes door-to-door in her village in Thailand, visiting every home to check people's
EU to use $2.7 billion fund to buy promising COVID-19 vaccines
By Reuters Staff BERLIN/BRUSSELS (Reuters) - The European Union is preparing to use an emergency 2.4-billion- euro ($2.7 billion) fund to make advance purchases of promising vaccines against the new
Inovio plans human trials for potential COVID-19 vaccine in South Korea in June
By Reuters Staff (Reuters) - Inovio Pharmaceuticals Inc said on Thursday it plans to begin human trials of its potential COVID-19 vaccine in South Korea later in June, with support from
Trump administration selects 5 coronavirus vaccine candidates as finalists -NYT
By Reuters Staff (Reuters) - The Trump administration has selected five companies, including Moderna Inc, AstraZeneca Plc and Pfizer Inc, as the most likely candidates to produce a vaccine for the
ANALYSIS-Does drug touted by Trump work on COVID-19? After data debacle, we still don't know
By Kate Kelland and Alistair Smout LONDON (Reuters) - Scientists are resuming COVID-19 trials of the now world-famous drug hydroxychloroquine, as confusion continues to reign about the anti-malarial
Roche IL-6 test receives FDA emergency use approval for COVID-19 patients
By Reuters Staff ZURICH (Reuters) - Drugmaker Roche has received emergency use authorisation from the U.S. Food and Drug Administration for its Elecsys IL-6 test to help identify severe inflammatory
Rituximab with chemotherapy effective against advanced childhood Burkitt's lymphoma
By Gene Emery (Reuters Health) - Six doses of rituximab can help children with high-grade, high-risk mature B-cell non-Hodgkin's lymphoma live longer, but at a risk of infections and
Jury out on benefits, harms of ventilation strategies for COVID-19
By Marilynn Larkin NEW YORK (Reuters Health) - Evidence is lacking on the effectiveness of noninvasive ventilation (NIV) and invasive mechanical ventilation (IMV) for COVID-19 patients, and the safety
Migraines during pregnancy associated with increased maternal stroke risk
By Lisa Rappaport (Reuters Health) - Women who experience migraines during pregnancy are more likely to have a stroke during pregnancy, delivery, or the postpartum period, a new study suggests.
IntelliCare mobile apps associated with improved anxiety, depression
By Lisa Rappaport (Reuters Health) - IntelliCare, a coach-supported suite of apps designed to improve mental health, may help ease depression and anxiety symptoms in primary care patients, a small
COVID SCIENCE-Convalescent plasma not helpful in China study; timing of test may affect result
By Nancy Lapid June 3 (Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the
Even with 10-day wait, suicide by gun 100 times higher within month of purchase
By Gene Emery (Reuters Health) - The risk of suicide by firearm jumps 100-fold during the first month after purchasing a handgun, even if the buyer is subject to a 10-day waiting period, according to
Malaria drug touted by Trump ineffective to prevent COVID-19 in high profile study
By Michael Erman (Reuters) - The malaria drug promoted by U.S. President Donald Trump as a treatment for COVID-19 was shown to be ineffective in preventing infection in people exposed to the
'Global epicenter' of problematic cholesterol has shifted
By Linda Carroll (Reuters Health) - High cholesterol is on the rise in low- and middle-income countries while declining in wealthier ones, an international team of researchers finds in a new analysis.
Vaccine group plans advance market agreement for COVID-19 vaccines
By Kate Kelland LONDON (Reuters) - The GAVI vaccines alliance is to launch an Advance Market Commitment (AMC) for future COVID-19 vaccines which it says will help secure access to the new shots for
Dutch coronavirus study: children are not big spreaders
By Reuters Staff AMSTERDAM (Reuters) - A study by the Netherlands' National Institute for Health (RIVM) published on Wednesday concluded that children under the age of 12 play little role in
WHO set to resume hydroxychloroquine trial in battle against COVID-19
By Michael Shields and Emma Farge GENEVA (Reuters) - The World Health Organization will resume its trial of hydroxychloroquine for potential use against the coronavirus, its chief said on Wednesday,
Brazil to start testing Oxford vaccine against the coronavirus this month
By Eduardo Simões SAO PAULO (Reuters) - Brazil this month will start testing an experimental vaccine against the novel coronavirus being developed by researchers at the University of Oxford and
Vietnam says most serious COVID-19 patient on path to recovery
By Reuters Staff HANOI (Reuters) - Vietnam's most gravely-ill COVID-19 patient, a British pilot who works for its national airline, has started to recover from the illness and may no longer require a
Coagulation abnormalities complicate mechanical thrombectomy in stroke patients with COVID-19
By Will Boggs MD NEW YORK (Reuters Health) - Coagulation abnormalities can interfere with mechanical thrombectomy and successful revascularization in stroke patients with COVID-19, according to a new
High plasma viscosity seen in critically ill COVID-19 patients
By Anne Harding NEW YORK (Reuters Health) - Abnormally high plasma viscosity could be contributing to the thrombotic complications seen in many COVID-19 patients, a new report suggests. Dr. Cheryl L.
Doctors can help parents cope in the NICU
By Carolyn Crist NEW YORK (Reuters Health) - Parenting a newborn can be a tough journey, and bonding with a new baby in a neonatal intensive-care unit (NICU) is even more difficult given the medical
Adjuvant osimertinib boosts disease-free survival in early non-small-cell lung cancer
By Megan Brooks NEW YORK (Reuters Health) - Treatment with osimertinib after surgery for localized, non-small-cell lung cancer (NSCLC) harboring EGFR mutations significantly improved disease-free
'Encouraging' results in trial of FOLFIRINOX for advanced gastroesophageal cancer
By Anne Harding NEW YORK (Reuters Health) - A four-drug combination is associated with improved overall and progression-free survival (PFS) in patients with advanced gastroesophageal adenocarcinoma, a
Kids with ADHD often on multiple medications
By Megan Brooks NEW YORK (Reuters Health) - Rates of psychotropic polypharmacy in children with attention-deficit/hyperactivity disorder (ADHD) continue to rise in the U.S., according to a national
COVID-19 exacts high toll in patients with diabetes
By Megan Brooks NEW YORK (Reuters Health) - About one in 10 patients with diabetes dies within seven days of being hospitalized with COVID-19 and one in five requires intubation for mechanical
COVID-19 more common with ApoE e4 genotype
By Will Boggs MD NEW YORK (Reuters Health) - Homozygosity for the ApoE e4 genotype appears to be associated with a higher rate of COVID-19, according to new findings. "We presented data on UK Biobank
Mortality spiked 155% in Spain in worst week of epidemic
By Emma Pinedo MADRID (Reuters) - New official data in Spain showed on Wednesday that many more people have died than usual this year than the recorded number of coronavirus fatalities and revealed a
Coronavirus is not high threat to workers, EU says, causing outcry
By Francesco Guarascio BRUSSELS (Reuters) - The European Commission classified the new coronavirus as a mid-level threat to workers, drawing criticism from socialist lawmakers because the move will
COVID-19 death toll among nurses doubled in past month, says nurses group
By Cecile Mantovani GENEVA (Reuters) - More than 600 nurses worldwide are known to have died from COVID-19, which has infected an estimated 450,000 healthcare workers, the International Council of
UK doctors to trial ibuprofen in COVID-19 patients with breathing difficulties
By Reuters Staff LONDON (Reuters) - British doctors are trialling a formulation of anti-inflammatory ibuprofen to see if it reduces respiratory failure in patients with severe symptoms of COVID-19.
UPDATE 1-Study panning anti-malaria drug Trump took against COVID faces new questions
(Adds details, NEJM concern, changes headline of story originally published June 2) By Michael Erman NEW YORK (Reuters) - British medical journal The Lancet on Tuesday said it had concerns (
Risks of surgery may be higher when coronavirus is circulating
By Linda Carroll (Reuters Health) - In a review of data on more than 1,000 postoperative patients with COVID-19, an international team of researchers found that half experienced complications, such as
Reasonable to expect some coronavirus vaccine by year-end -Pentagon researcher
By David Brunnstrom, Carl O'Donnell and Julie Steenhuysen WASHINGTON (Reuters) - A senior U.S. Army vaccine researcher said on Tuesday it was reasonable to expect that some sort of coronavirus vaccine
Medical journal concerned about validity of influential hydroxychloroquine study
By Michael Erman NEW YORK (Reuters) - British medical journal The Lancet on Tuesday said it had concerns (https://bit.ly/300q8Bp) about data behind an influential article that found hydroxychloroquine
Racial disparities in receipt of opioid use disorder drugs among U.S. pregnant women
By Lisa Rapaport (Reuters Health) - Pregnant women with opioid use disorder are more likely to receive medications such as methadone or buprenorphine when they're white than when they're Hispanic or
Loss of smell, taste with COVID-19 more prevalent than previously thought
By Marilynn Larkin NEW YORK (Reuters Health) - The prevalence of self-reported smell and taste dysfunction in COVID-19 is higher than previously thought and may present in different ways, researchers
Peer leadership, sports-team logos help homeless youth mask up
By Anne Harding NEW YORK (Reuters Health) - Young people who are respected by their peers can motivate those peers to adopt healthy behaviors, a new report on mask-wearing among youth living in
Tucatinib a 'game changer' in HER+ breast cancer with brain metastases
By Megan Brooks NEW YORK (Reuters Health) - In patients with HER2+ metastatic breast cancer (MBC) with brain lesions, adding tucatinib to trastuzumab and capecitabine significantly delays progression
COVID-19 illness appears less severe in children, review confirms
By Will Boggs MD NEW YORK (Reuters Health) - More evidence that children with COVID-19 appear to have less severe disease than adults comes from a new review. "There are several obstacles to the
Appendicitis admissions declining during COVID-19 pandemic
By Reuters Staff NEW YORK (Reuters Health) - The number of admissions for acute appendicitis has declined significantly since the beginning of the COVID-19 pandemic, researchers in Israel report.
Compression stockings may not help prevent clots after elective surgery
By Lisa Rapaport (Reuters Health) - Adding compression stockings to heparin doesn't work any better than heparin alone for preventing venous thromboembolism (VTE) after elective surgery, a
INTERVIEW-AIDS took away our freedom. The pandemic is doing the same, says Patti Smith
By Rachel Savage LONDON (Thomson Reuters Foundation) - Since punk rock pioneer Patti Smith agreed to write the introduction to a new version of "De Profundis," the anguished letter Oscar Wilde wrote
SPECIAL REPORT-U.S. school closures dramatically shrinking public education, Reuters finds
By M.B. Pell, Kristina Cooke and Benjamin Lesser NEW YORK (Reuters) - Jennifer Panditaratne's third-grade daughter had been seeing a reading specialist once a week before her Florida school closed
Indian girl's suicide sparks protest over access to online classes
By Jose Devasia KOCHI (Thomson Reuters Foundation) - Students protested in southern India on Tuesday after the suicide of a teenage girl who was unable to attend online classes because she did not
EU eyes overhaul of pharma rules to tackle vaccine, antibiotic shortages
BRUSSELS, June 2 (Reuters) - The European Commission on Tuesday started a process that could lead to reforms of drug manufacturing to limit shortages of vaccines and antibiotics and make medicines
Dehydration pathway for pediatric gastroenteritis may cut resource use, costs
By Reuters Staff NEW YORK (Reuters Health) - Implementation of an evidence-based algorithm for managing pediatric gastroenteritis was followed by a significant reduction in IV-fluid administration and
Longer rituximab therapy boosts remission in ANCA-associated vasculitis
By Will Boggs MD NEW YORK (Reuters Health) - Long-term rituximab use lowers the chance of relapse of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), compared with standard
Evolocumab curbs risks in patients with recent MIs
By David Douglas NEW YORK (Reuters Health) - Treatment with the PCSK9 inhibitor evolocumab (Repatha, Amgen) in patients who have experienced an myocardial infarct (MI) within 12 months reduces risk
UPDATE 1-Japan allows saliva-based tests to boost coronavirus detection
(Updates with alert from Tokyo government) By Kiyoshi Takenaka TOKYO (Reuters) - Japan's government said on Tuesday it has approved saliva-based tests for the new coronavirus, offering a safer,
UPDATE 1-New virus cluster spurs Hong Kong to extend border curbs and limit on gatherings
By Donny Kwok HONG KONG (Reuters) - Voicing worries over a new cluster of coronavirus cases, Hong Kong decided on Tuesday to keep its borders almost completely closed to foreigners until mid-September
Frequent testing, less contact recommended to get Hollywood cameras rolling again
By Reuters Staff LOS ANGELES (Reuters) - Hollywood studios and labor unions on Monday proposed extensive coronavirus testing and other safeguards to allow actors and crew members to resume movie and
Japan allows saliva-based tests to boost coronavirus detection
By Kiyoshi Takenaka TOKYO (Reuters) - Japan's government said on Tuesday it has approved saliva-based tests for the new coronavirus, offering a safer, simpler way to diagnose infection than nasal
No new COVID sufferers, 300 asymptomatic, after Wuhan-wide tests
By Reuters Staff BEIJING (Reuters) - The Chinese city of Wuhan, where the novel coronavirus outbreak began, has found no new cases of people suffering from COVID-19 after testing almost its entire
'Often mistrusted': UK stats watchdog criticises COVID-19 test data
By Andy Bruce LONDON (Reuters) - Britain's statistics watchdog chided the government on Tuesday for publishing data on coronavirus tests that it said were "far from complete and comprehensible". "The
Black and Asian people in England more likely to die from COVID-19, says public health report
By Reuters Staff LONDON (Reuters) - Black and Asian people in England are up to 50% more likely to die after being infected with COVID-19, an official study said on Tuesday, reinforcing previous
UK records almost 62,000 excess deaths during pandemic: ONS official
By Reuters Staff LONDON (Reuters) - Some 62,000 more people than usual have died in the United Kingdom during this year's coronavirus pandemic according to the latest available data, an expert from
S.Korea expects human trials of Celltrion's potential COVID-19 treatment in Europe
By Reuters Staff SEOUL (Reuters) - South Korea expects clinical trials of Celltrion Inc's experimental COVID-19 monoclonal antibody to begin in Europe next month and aims to secure sizable supplies of
Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions
By Deena Beasley (Reuters) - Gilead Sciences Inc is developing easier-to-administer versions of its antiviral treatment remdesivir for COVID-19 that could be used outside of hospitals, including ones
Proteins in COVID-19 patients' blood could predict severity of illness, study finds
By Kate Kelland LONDON (Reuters) - Scientists have found 27 key proteins in the blood of people infected with COVID-19 which they say could act as predictive biomarkers for how ill a patient could
Privately insured diabetes patients 'relatively shielded' from insulin price increases
By Megan Brooks NEW YORK (Reuters Health) - A new study discounts the notion that insulin cost-sharing is excessive for privately insured patients. Despite the rising price of insulin paid by
Global Covid-19 pandemic could lead to 28 million surgeries canceled worldwide
By Lisa Rapaport (Reuters Health) - An estimated 28.4 million elective surgeries worldwide will be cancelled during the 12 weeks of peak disruption due to the global Covid-19 pandemic, according to a
U.S. court refuses to shield VW in diesel scandal lawsuits
By David Shepardson and Jonathan Stempel (Reuters) - A U.S. appeals court ruled on Monday that Volkswagen AG cannot escape potential financial penalties from two counties in Florida and Utah that may
U.S. EPA moves to curb state powers to deny permits for energy projects
By Valerie Volcovici WASHINGTON (Reuters) - U.S. Environmental Protection Agency chief Andrew Wheeler signed on Monday a rule limiting state powers to block energy infrastructure projects, setting up
Hidradenitis suppurativa tied to increased cancer risk
By Marilynn Larkin NEW YORK (Reuters Health) - Hidradenitis suppurativa (HS) was associated with an increased risk of cancer in a population-based study in Korea. Dr. Mi Woo Lee of the University of
SARS-CoV-2 can enter brain through olfactory tract
By Will Boggs MD NEW YORK (Reuters Health) - MRI brain changes in a patient with COVID-19 and anosmia are consistent with SARS-CoV-2 invasion by way of the olfactory tract, researchers report. "Based
Paper towel soaked in salt water may improve masks' ability to block viruses, bacteria
By Linda Carroll (Reuters Health) - When paper towels are soaked in a saline solution and then allowed to dry, they can effectively filter out particles comparable in size to the SARS-CoV-19 virus, a
Patient-related factors key to COVID-19 disease severity
By Marilynn Larkin NEW YORK (Reuters Health) - Patient-related factors, including age, lymphocytopenia and cytokine levels are associated with COVID-19 disease severity, according to researchers in
UPDATE 1-Wildlife groups up pressure on Big Pharma to curb crab blood addiction
(Adds Eli Lilly comments) By John Miller ZURICH (Reuters) - Wildlife advocates are pushing drugmakers to curb the use of horseshoe crab blood by switching to a synthetic alternative for safety tests,
American Indians, Alaska natives less likely to get optimal therapy for atrial fibrillation
By Marilynn Larkin NEW YORK (Reuters Health) - American Indians and Alaska natives (AI/ANs) with atrial fibrillation (AF) are less likely to be treated with oral anticoagulants (OACs) and rhythm
Italy launches COVID-19 contact-tracing app amid privacy concerns
By Reuters Staff ROME (Reuters) - Italy on Monday released a contested mobile app to trace coronavirus infections in four regions before extending it to the whole country, despite widespread
